Novartis Ag NVS
NYSE NVS
$153.95 +0.31 (+0.20%)
As of: Oct 21, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Deferred Taxes (2018 - 2019)

Updated

Novartis Ag's Deferred Taxes came in at -$398 million for Q2 2026, compared with -$675 million a year earlier.

Analysis

Novartis Ag (NVS) Deferred Taxes (2018 - 2019) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Deferred Taxes of -$2.53 billion; for FY2025, it was -$2.56 billion.

  • Going back by year, Deferred Taxes was -$2.26 billion in FY2024, -$2.79 billion in FY2023, -$1.7 billion in FY2022 and -$1.86 billion in FY2021.
  • The five-year range for quarterly Deferred Taxes is -$1.09 billion (Q4 2023) to -$260 million (Q3 2022).
  • Business Quant data shows NVS's Deferred Taxes at -$787 million (Q1 2026), -$981 million (Q4 2025) and -$366 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -479.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -195.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -587.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.32 Bn
10 Vertex Pharmaceuticals 133.33 Bn 105.34 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 33.03 Bn
Dec 31, 2018 43.92 Bn
API Access

Novartis Ag Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=NVS&period=max&api_key=YOUR_API_KEY